drugset / Trial / NCT04262765

Drug-drug-interaction Study of Ramipril, Amlodipine and Atorvastatin

NCT04262765

Phase 1 Completed 18 enrolled Midas Pharma GmbH
NaSingle-groupOpen-labelTreatment

Summary

Study to determine the potential pharmacokinetic interaction of ramipril (and ramiprilat), atorvastatin as atorvastatin calcium trihydrate and amlodipine as amlodipine besilate at steady state after a multiple oral administration and to monitor the safety of the co-administration of these drugs. This study aims to determine if the steady state study pharmacokinetic parameters of any of the given drugs and the tolerability is altered when administered concomitantly.

Timeline

Start
2019-02-23
Primary completion
2019-03-26
Completion
2019-03-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified Oral
Subject Atorvastatin Small molecule Oral
Subject Ramipril Small molecule Oral

Indications

No indication recorded.